πŸ‡ΊπŸ‡Έ FDA
Patent

US 9498468

Rhinitis treatment regimens

granted A61KA61K31/137A61K31/439

Quick answer

US patent 9498468 (Rhinitis treatment regimens) held by Pharmaceutical Design, LLC expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmaceutical Design, LLC
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/137, A61K31/439, A61K31/44, A61K31/4402